| Advanced Biomed Inc. (ADVB) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2026 | Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | |
| Balance Sheet Date | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | ||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | ||||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (583,268$) | (239,775$) | (513,558$) | (610,342$) | (1,543,962$) | (3,409,572$) | (29,680$) | (475,828$) | (1,065,658$) | ||||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | (2,490,146$) | (1,264$) | (12,906$) | (1,771$) | (20,149$) | (2,215$) | (19,978$) | (53,256$) | 26,699$ | ||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 1,264$ | 12,906$ | 1,771$ | 20,149$ | 2,215$ | 19,978$ | 53,256$ | (26,699$) | |||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 936,756$ | 268,277$ | 315,477$ | 447,462$ | (765,466$) | 5,898,956$ | 392,525$ | 323,536$ | 562,199$ | ||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 385,535$ | 2,602,697$ | 2,604,666$ | 2,656,519$ | 31,139$ | 3,176,462$ | 2,647,656$ | 2,646,992$ | 2,607,973$ | 2,663,704$ | 2,776,622$ | ||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | (86,430$) | (29,207$) | (39,871$) | (82,745$) | 267,738$ | 39,696$ | 367,550$ | (303,848$) | 149,817$ | 363,842$ | |||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (583,268$) | (241,039$) | (526,464$) | (612,113$) | (1,564,111$) | (3,411,787$) | (49,658$) | (529,084$) | (1,038,959$) | ||||||||||||||||||||||||||||||||||||||||